Gene therapy for age-related macular degeneration
Age-related macular degeneration is the most common cause of untreatable blindness in the world, and its prevalence is increasing. Current therapies for neovascular age-related macular degeneration aim to prevent growth of the abnormal retinal blood vessels that could leak and cause rapid visual los...
Main Author: | MacLaren, RE |
---|---|
Format: | Journal article |
Published: |
Elsevier
2015
|
Similar Items
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
by: Borchert, GA, et al.
Published: (2024) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
by: Borchert, GA, et al.
Published: (2024) -
Radiotherapy for neovascular age-related macular degeneration.
by: Evans, JR, et al.
Published: (2010) -
The complement system and age-related macular degeneration.
by: Sivaprasad, S, et al.
Published: (2006) -
Choriocapillaris Loss in Advanced Age-Related Macular Degeneration
by: Moreira-Neto, Carlos A., et al.
Published: (2018)